Literature DB >> 8359189

The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.

T Shiga1, A Fujimura, T Tateishi, K Ohashi, A Ebihara.   

Abstract

There is diurnal variation in the absorption rate of propranolol in younger subjects. This study was undertaken to examine the effect of age on the chronopharmacokinetics of propranolol. We gave 20 mg of propranolol orally to 13 younger and 11 older hypertensive subjects at 09.00 h (day study) or 21.00 h (night study) in a cross-over design. Plasma concentrations of propranolol and its metabolites, 4-hydroxypropranolol and naphthoxylactic acid, were determined just before and at 0.5, 1, 1.5, 2, 3, 4, 6, 12, and 24 h after dosage. In the younger subjects the absorption rate constant (ka) of propranolol and its maximum plasma concentration (Cmax) were significantly higher and the time to maximum concentration (tmax) was significantly shorter in the day than at night. There were similar time-variant changes in Cmax and tmax for 4-hydroxypropranolol and naphthoxylactic acid. In contrast, there were no time-variant changes in ka, Cmax and tmax of propranolol and its metabolites in the older subjects. These results suggest that propranolol is absorbed more rapidly after morning dosing than after night-time dosing in younger but not in older subjects. Based on these findings, we speculate that the time-variance in the absorption rate or first-pass elimination, or both, of propranolol diminish with age.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359189     DOI: 10.1007/bf00315550

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Circadian esophageal motor function in patients with gastroesophageal reflux disease.

Authors:  H J Stein; E P Eypasch; T R DeMeester; T C Smyrk; S E Attwood
Journal:  Surgery       Date:  1990-10       Impact factor: 3.982

2.  Twenty-four-hour pattern of esophageal motility in asymptomatic volunteers.

Authors:  D Armstrong; C Emde; R Bumm; F Castiglione; T Cilluffo; A L Blum
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

Review 3.  Rhythms in morphology and function of hepatocytes.

Authors:  Y Uchiyama
Journal:  J Gastroenterol Hepatol       Date:  1990 May-Jun       Impact factor: 4.029

4.  Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.

Authors:  A Fujimura; Y Kumagai; K Sugimoto; H Nakashima; H Kajiyama; A Ebihara; K Ohashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Effects of age and cigarette smoking on propranolol disposition.

Authors:  R E Vestal; A J Wood; R A Branch; D G Shand; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

6.  Time-dependent absorption of theophylline in man.

Authors:  H Watanabe; S Nakano; K Nagai; N Ogawa
Journal:  J Clin Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.126

7.  Ambulatory 24-hr pH monitoring of esophagus, fundus, and antrum. A new technique for simultaneous study of gastroesophageal and duodenogastric reflux.

Authors:  S Mattioli; V Pilotti; V Felice; A Lazzari; R Zannoli; M L Bacchi; P Loria; A Tripodi; G Gozzetti
Journal:  Dig Dis Sci       Date:  1990-08       Impact factor: 3.199

8.  A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.

Authors:  J W Rigby; A K Scott; G M Hawksworth; J C Petrie
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

9.  Circadian changes in estimated hepatic blood flow in healthy subjects.

Authors:  B Lemmer; G Nold
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

10.  The influence of diltiazem versus cimetidine on propranolol metabolism.

Authors:  T Tateishi; K Ohashi; A Fujimura; A Ebihara
Journal:  J Clin Pharmacol       Date:  1992-12       Impact factor: 3.126

View more
  1 in total

Review 1.  Chronopharmacokinetics. Current status.

Authors:  B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.